News and Media

Tchaikapharma High Quality Medicines Inc. received Marketing Authorization for Pizona – a new medicine for diabetes.

Tchaikapharma High Quality Medicines Inc. received new Marketing Authorization for the medicinal product Pizona 15 mg, Pizona 30 mg and Pizona 45 mg tablets subject to medical prescription.

Pizona contains the active substance pioglitazone and is an anti-diabetic medicine used to treat type 2 (non-insulin dependent) diabetes mellitus. This is the diabetes, which usually occurs in adults.

Pizona helps control the level of blood sugar in type 2 diabetes by helping the body better use the insulin it produces. The attending physician checks whether Pizona is producing the desired effect within 3 to 6 months after initiation of the therapy.

Pizona tablets may be used alone or in combination with metformin and/or sulfonylurea derivatives, which are also oral antidiabetics. The medicament may also be used in combination with insulin.

The team of “Tchaikapharma High Quality Medicines” wishes you warm and happy Christmas and New Year holidays!

Smartphones and special devices that transmit data via Bluetooth will remind elderly patients over 65 years when to drink their medications, when it is time to measure their blood pressure, pulse or when to go for a check-up.

This is a plan of the European Commission, supported by the Sofia Mayor Yordanka Fandakova, by the Sofia Municipality and district “Triaditza”. The pilot plan includes 100 retirees with at least one chronic disease, said the manager of the program Dr. Stoycho Katsarov from the Center for Protection of the Rights in Healthcare. “The goal is better health, safety and independent living for Bulgarians over 65 years,” added Dr. Katzarov. The analysis of the results will be used by the European Commission to develop a European policy for integrated health and social care.

The selected in Bulgaria patients satisfy the conditions to not be accommodated in a rest home, to be a receiver of at least of one social care service like a social or personal assistant, patronage, to be at risk of isolation and to not suffer from severe mental disorders. The smartphones and devices they have been given will not only monitor their life indicators, but also their body weight, the environment temperature, and their locomotor activity.

“All the data will be collected in a database, and it will register the medical and social care services received by the senior (meaning the diagnoses, the therapies, and the check ups),”- said Dr. Katzarov.

The expert said that an all-day call center will be built for a permanent connection with the project participants. It will include GPs and social workers. “The project is for the period of three years, and it was launched on the 1^st of February this year, but the monitoring of patients starts on the 1^st of February 2015,” – said Dr. Katzarov.

The cost of the initiative is € 5,000,000. Bulgaria receives € 500 000 and 250 000 of them – is non-repayable. “Once the program is completed, we can determine what kind of services seniors require, what are the problems they most often encounter. And our health and social services will know in which direction to focus their efforts and what is the required care, which we now lack that has to be provided,”- said the doctor. According to the EC this is the only way we can effectively manage the demographic changes and lifestyles in Europe and to focus on the lives of the elderly.

In connection with the upcoming holidays and the days off work the NHIF informed that the general practitioners and specialists can prescribe, and pharmacies – grant, medicinal products to the insured persons earlier than the stipulated 30 days.

The next prescription should be made on the date when the received by the insured person medicines, dispensed on prescription from the last two visits to the pharmacy, are finished.

The period for which the prescribed drugs dispensed on the previous occasion and the holiday one should last is reflected in the ambulatory sheet. It and the new prescription form record the exact date for the next drugs prescription.

In healthcare money is never enough anywhere, even in the richest countries, stated the manager of the NHIF Dr. Rumyana Todorova in response to the question whether she was pleased with the NHIF budget for 2015. “But if we concentrate, we should say ‘yes’”, – she indicated and pointed out once again that the sum is by BGN 252 million more than the originally adopted by the Parliament budget for 2014

„In my view, the money would not be enough“,- she said just the same and explained: „Relative tranquility will be brought into the system, but there are certain objective laws in healthcare, which, no matter what the budget is, no matter how well calculated it is, cannot be covered 100%.” Dr. Todorova noted that there is a continuous increase in the number of patients and once again noted that the annual average number of cancer patients increases by about 9000, which means nearly BGN 70 million to the NHIF. “Of course, this is related to the constantly improving diagnosis and new technologies. On the other hand, the access to better medicines prolongs life and enhances the credibility of the institution and the resorting of patients to the mandatory health insurance increases, “- she said.

According to the manager of the NHIF there will be a change, but it can not happen all of a sudden. “For me 2015 will be a buffer year, during which we will work on legislative changes and at the same time we will use all the opportunities for the control and correct targeting of cash flows, while these reforms are taking place,” she said, adding that according to her a year is absolutely sufficient to lay the foundation for the changes.

Dr. Todorova said that the medical referrals will not become inapplicable in 2015 and that they are a form of control in outpatient care. “On the other hand there is a proposal by the BMA for them to participate in the methodology for the allocation of funds to hospitals and to participate actively in the control. There is even a proposal by them for 90% of the resources which were actually paid the Health Fund in 2014 to be distributed for 2015,” – she informed.

Regarding the problem with the drug costs the NHIF manager commented: “Drugs are in the hands of the physician and logically it has to be so. The doctor is the one who will choose which medication to use, what is the most suitable thing for the patient. No financial institution can say that. Perhaps this is the place where the insurance institutions should become operative. I.e. there should be an additional resource, because with this resource the Fund cannot cover everything.” She brought up the medicines for rare diseases as well, which were transferred to the NHIF in 2011. At that time the Fund paid for them BGN 24 million, while now the amount is BGN 69 million, reported Dr. Todorova.

And, once again the manager of the NHIF brought up the slashed control capacity of the Fund regarding the money that has been spent by it. She indicated that the financial penalties, which the institution can impose if irregularities are detected, range between BGN 200 and 500, and asked: “Should not the sanctions in the “Control” department be more serious? Should they only be in cash? Should we focus on terminating the contract with the establishment, if it has not performed the action? ”

The state has to warm to its role, summed up Dr. Rumyana Todorova and clarified: “As well as to pay its health insurance contributions as much as we pay and to warm to its role of a regulator and guardian of this system.”